24
Views
2
CrossRef citations to date
0
Altmetric
IWNHL Supplement

Vaccine Therapy in NHL: Future Promises and Current Limitations

, &
Pages S85-S90 | Published online: 20 Apr 2011

References

  • Chang, M.H., Chen, C.J., Lai, M.S., Hsu, H.M., Wu, T.C., Kong, M.S., et al. Taiwan Childhood Hepatoma Study Group. (1997) "Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children", New England Journal of Medicine, 336, 1855–1859.
  • Chang, M.H., Shau, WY., Chen, C.J., Wu, T.C., Kong, M.S., Liang, D.C., et al. Taiwan Childhood Hepatoma Study Group. (2000) "Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls", Journal of the American Medical Association, 284, 3040— 3042.
  • Furumoto, H. and Irahara, M. (2002) "Human papilloma virus (HPV) and cervical cancer", Journal of Medical Investigation, 49, 124 — 133.
  • Eckhart, W. (1998) "Viruses and human cancer", Science Progress, 81, 315–328.
  • Stevenson, G.T. (1977) "Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target", Federation Proceedings, 36, 2268–2271.
  • Maloney, D.G. (1998) "Advances in immunotherapy of hematolo-gic malignancies", Current Opinions in Hematology, 5, 237–243.
  • Schultze, J.L., Cardoso, A.A., Freeman, G.J., Seamon, M.J., Daley, J., Pinkus, G.S., et al. (1995) "Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity", Proceedings of the National Academy of Sciences of the United States of America, 92, 8200–8204.
  • Ranheim, E.A. and Kipps, T.J. (1993) "Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal", Journal of Experimental Medicine, 177, 925–935.
  • Yellin, M.J., Sinning, J., Covey, L.R., Sherman, W., Lee, Glickman-Nir, E., et al. (1994) "T lymphocyte T cell-B cell activating molecule/CD4O-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity", Journal of Immunology, 153, 666–674.
  • Van den Hove, L.E., Van Gool, S.W., Vandenberghe, P., Bakkus, M., Thielemans, K., Boogaerts, M.A., et al. (1997) "CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules", Leukemia, 11, 572–580.
  • Boon, T. and van der Bruggen, P. (1996) "Human tumor antigens recognized by T lymphocytes", Journal of Experimental Medicine, 183, 725–729.
  • Rosenberg, S.A. (1999) "A new era for cancer immunotherapy based on the genes that encode cancer antigens", Immunity, 10, 281–287.
  • Berd, D., Maguire, H.C., McCue, P. and Mastrangelo, M.J. (1990) "Treatment of metastatic melanoma with an autologous tumor-cell vaccine: Clinical and immunologic results in 64 patients", Journal of Clinical Oncology, 8, 1858— 1867.
  • Mitchell, M.S., Kan-Mitchell, J., Kempf, R.A., Harel, W., Shau, H.Y. and Lind, S. (1988) "Active specific immunotherapy for melanoma: phase I trial of allogenic lysates and a novel adjuvant", Cancer Research, 48, 5883–5893.
  • Casares, N., Lasarte, J.J., de Cerio, AL., Sarobe, P., Ruiz, M., Melero, I., et al. (2001) "Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Thl helper peptide elicits protective CTL immunity", European Journal of Immunology, 31, 1780 — 1789.
  • Okamoto, T., Kaneda, Y., Yuzuki, D., Huang, S.K., CM, D.D. and Hoon, D.S. (1997) "Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine", Gene Therapy, 4, 969–976.
  • Murphy, G.P., Tjoa, BA., Simmons, Si., Ragde, H., Rogers, M., Elgamal, A., et al. (1999) "Phase II prostate cancer vaccine trial: report of a study, involving 37 patients with disease recurrence following primary treatment", Prostate, 39, 54— 59.
  • Hsu, F.J., Benike, C., Fagnoni, F., Liles, TM., Czerwinski, D., Taidi, B., et al. (1996) "Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells", Nature Medicine, 2, 52–58.
  • Hang, S., Witzens, M., Krackhardt, AM., Trojan, A., Barrett, P., Broderick, R., et al. (2001) "Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues", Blood, 98, 2999 — 3005.
  • Muller, D., Pederson, K., Murray, R. and Frelinger, J.A. (1991) "A single amino acid substitution in and MHC class I molecule allows heteroclitic recognition by lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes", Journal of Immunology, 147, 1392 — 1397.
  • Lowrie, D.B., Tascon, RE., Bonato, V.L., Lima, V.M., Faccioli, L.H., Stavropoulos, E., et al. (1999) "Therapy of tuberculosis in mice by DNA vaccination", Nature, 400, 269–271.
  • Klinman, D.M., Yi, AK., Beaucage, S.L., Conover, J. and Krieg, AM. (1996) "CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFN),", Proceedings of the National Academy of Sciences of the United States of America, 93, 2879–2883.
  • Boczkowski, D., Nair, S., Snyder, D. and Gilboa, E. (1996) "Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo", Journal of Experimental Medicine, 184, 465–472.
  • Nair, S.K., Morse, M., Boczkowski, D., Cumming, RI., Vasovic, L., Gilboa, E., et al. (2002) "Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells", Annals of Surgery, 235, 540— 549.
  • Ulmer, J.B., Donnelly, Li., Parker, SE., Rhodes, G.H., Feigner, P.L., Dwarki, Vi., et al. (1993) "Heterologous protection against influenza by injection of DNA encoding a viral protein", Science, 259, 1745 — 1749.
  • Wolff, JA., Malone, R.W., Williams, P., Chong, W., Acsadi, G., Jani, A., et al. (1990) "Direct gene transfer into mouse muscle in vivo", Science, 247, 1465 — 1468.
  • Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M.D., et al. (1996) "Immunostimulatory DNA sequences necessary for effective intradermal gene immunization", Science, 273, 352— 354.
  • Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C. and Robinson, H.L. (1993) "DNA vaccines: protective immunization by parenteral, mucosal and gene-gun inoculations", Proceedings of the National Academy of Sciences of the United States of America, 90, 11478 — 11482.
  • Jones, D.H., Corns, S., McDonald, S., Clegg, J.C. and Farrar, G.H. (1997) "Poly (DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration", Vaccine, 15, 814–817.
  • Nabel, G.J., Nabel, E.G., Yang, Z.Y., Fox, BA., Plautz, G.E., Gao, X., et al. (1993) "Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans", Proceedings of the National Academy of Sciences of the United States of America, 90, 11307 — 11311.
  • Widera, G., Austin, M., Rabussay, D., Goldbeck, C., Barnett, S.W., Chen, M., et al. (2000) "Increased DNA vaccine delivery and immunogenicity by electroporation in vivo", Journal of Immunology, 164, 4635–4640.
  • Kwak, LW., Campbell, M.J., Czerwinski, D.K., Hart, S., Miller, R.A. and Levy, R. (1992) "Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors", New England Journal of Medicine, 327, 1209 — 1215.
  • Hawkins, RE., Zhu, D., Ovecka, M., Winter, G., Hamblin, T.J., Long, A., et al. (1994) "Idiotypic vaccination against human B-cell lymphoma: rescue of variable region gene sequences from biopsy material for assembly as single chain Fv 'personal' vaccines", Blood, 83, 3279 — 3288.
  • Anderson, R., Gao, X.M., Papakonnstantinopolou, A., Roberts, M. and Dougan, G. (1996) "Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin", Infection and Immunity, 64, 3168 — 3173.
  • Panina-Bordignon, P., Tan, A., Termijtelen, A., Demotz, S., Corradin, G. and Lanzavecchia, A. (1989) "Universally immuno-genic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells", European Journal of Immunology, 19, 2237–2242.
  • Spellerberg, M.B., Zhu, D., Thompsett, A., King, CA., Hamblin, T.J. and Stevenson, F.K. (1997) "DNA vaccines against lymphoma. Promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C", Journal of Immunology, 159, 1885— 1892.
  • King, CA., Spellerberg, M.B., Zhu, D., Rice, J., Sahota, S.S., Thompsett, AR., et al. (1998) "DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma", Nature Medicine, 4, 1281–1286.
  • Stevenson, F.K. (1999) "DNA vaccines against cancer: from genes to therapy", Annals of Oncology, 10, 1413–1418.
  • Thirdborough, S.M., Radcliffe, J.N., Friedmann, P.S. and Steven-son, F.K. (2002) "Vaccination with DNA encoding a single-chain TCR fusion protein induces anticlonotypic immunity and protects against T-cell lymphoma", Cancer Research, 62, 1757— 1760.
  • Savelyeva, N., Munday, R., Spellerberg, M.B., Lomonossoff, G.P. and Stevenson, F.K. (2001) "Plant viral genes in DNA idiotypic vaccines activate linked CD4 + T-cell mediated immunity against B-cell malignancies", Nature Biotechnology, 19, 760–764.
  • Rice, J., Buchan, S. and Stevenson, F.K. (2002) "Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen", Journal of Immunology, 169, 3908–3913.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.